J&J Unit Can't Shake $442M Loss In Catheter Antitrust Suit
By Bryan Koenig · August 28, 2025, 5:52 PM EDT
A California federal judge has refused to upend the $442 million trial loss of Johnson & Johnson's Biosense Webster health tech unit to Innovative Health, finding the jury was presented with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login